![Dag Åke Landegren](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dag Åke Landegren
Fondateur chez
Moleculink AB
Fortune : 3 213 $ au 30/06/2026
Profil
Dag Åke Ulf Landegren is the founder of Moleculink AB, where he holds the title of Director starting in 2004.
He is also the founder of ParAllele BioScience, Inc. In addition to his founding positions, Mr. Landegren previously held a Director position at Q-linea AB.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
Q-LINEA AB 0,01% | 29/01/2025 | 1 824 ( 0,01% ) | 3 213 $ | 30/06/2026 |
Postes actifs de Dag Åke Landegren
| Sociétés | Poste | Début |
|---|---|---|
Moleculink AB
 Moleculink AB Electronic Equipment/InstrumentsElectronic Technology Provides diagnostic products for life science research purposes | Fondateur | 01/01/2004 |
Anciens postes connus de Dag Åke Landegren
| Sociétés | Poste | Fin |
|---|---|---|
| Q-LINEA AB | Directeur/Membre du Conseil | 26/05/2020 |
ParAllele BioScience, Inc.
 ParAllele BioScience, Inc. Miscellaneous Commercial ServicesCommercial Services Develops biochemical processes to analyze variations in the human genome | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
13
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
ParAllele BioScience, Inc.
ParAllele BioScience, Inc. Miscellaneous Commercial ServicesCommercial Services Develops biochemical processes to analyze variations in the human genome | Commercial Services |
Moleculink AB
Moleculink AB Electronic Equipment/InstrumentsElectronic Technology Provides diagnostic products for life science research purposes | Electronic Technology |
Q-linea AB
 Q-linea AB Medical SpecialtiesHealth Technology Develops procedures, instruments, and systems for protein and nucleic acid analysis | Health Technology |
Choisissez Zonebourse 
